[go: up one dir, main page]

NO20044258L - Cystein proteaseinhibitor - Google Patents

Cystein proteaseinhibitor

Info

Publication number
NO20044258L
NO20044258L NO20044258A NO20044258A NO20044258L NO 20044258 L NO20044258 L NO 20044258L NO 20044258 A NO20044258 A NO 20044258A NO 20044258 A NO20044258 A NO 20044258A NO 20044258 L NO20044258 L NO 20044258L
Authority
NO
Norway
Prior art keywords
protease inhibitor
cysteine protease
cysteine
inhibitor
protease
Prior art date
Application number
NO20044258A
Other languages
English (en)
Norwegian (no)
Inventor
Akio Yamada
Yasushi Kawaguchi
Nobuhiko Katunama
Natsuko Takakura
Original Assignee
Morinaga Milk Industry Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Morinaga Milk Industry Co Ltd filed Critical Morinaga Milk Industry Co Ltd
Publication of NO20044258L publication Critical patent/NO20044258L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Communicable Diseases (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Virology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fodder In General (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20044258A 2002-11-29 2004-10-07 Cystein proteaseinhibitor NO20044258L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002347801 2002-11-29
JP2003147035 2003-05-23
PCT/JP2003/014263 WO2004050118A1 (fr) 2002-11-29 2003-11-10 Inhibiteur de la cysteine protease

Publications (1)

Publication Number Publication Date
NO20044258L true NO20044258L (no) 2004-10-28

Family

ID=32473655

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20044258A NO20044258L (no) 2002-11-29 2004-10-07 Cystein proteaseinhibitor

Country Status (8)

Country Link
US (1) US20050148504A1 (fr)
EP (1) EP1568377A1 (fr)
JP (1) JPWO2004050118A1 (fr)
KR (1) KR20050044758A (fr)
AU (1) AU2003277644A1 (fr)
CA (1) CA2481489A1 (fr)
NO (1) NO20044258L (fr)
WO (1) WO2004050118A1 (fr)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1503628A4 (fr) * 2002-04-29 2006-11-29 First Products Inc Produits surgeles de boulangerie pour fours a micro-ondes
US20080260926A1 (en) * 2003-04-29 2008-10-23 First Products, Inc. Frozen Microwavable Bakery Products
GB0423352D0 (en) * 2004-10-21 2004-11-24 Hannah Res Inst "Control of mammary cell number"
CN101084004A (zh) * 2004-12-22 2007-12-05 帝斯曼知识产权资产管理有限公司 单个酶促步骤中的血压降低寡肽
CN101272803B (zh) * 2005-09-30 2012-11-21 森永乳业株式会社 胰高血糖素样肽-1分泌促进剂、胰高血糖素样肽-1分泌促进用饮食品、餐后血糖值上升抑制剂和餐后血糖值上升抑制用饮食品
JP4536665B2 (ja) * 2006-02-08 2010-09-01 森永乳業株式会社 カゼイン加水分解物含有造粒物の製造方法
MX2008013344A (es) * 2006-04-20 2009-01-07 First Products Inc Productos de pasta congelados que pueden ser calentados en microondas.
EP2030629B1 (fr) * 2006-06-09 2014-04-30 Morinaga Milk Industry Co., Ltd. Alpha-s-casein comme agent d'amélioration du métabolisme des lipides
US20080124355A1 (en) 2006-09-22 2008-05-29 David Gordon Bermudes Live bacterial vaccines for viral infection prophylaxis or treatment
JP4956164B2 (ja) * 2006-12-06 2012-06-20 味の素株式会社 メラニン輸送及び／又は放出抑制剤
US9044486B2 (en) * 2008-04-02 2015-06-02 Cornell University Method for prophylaxis or treatment of feline infectious peritonitis
JP5261114B2 (ja) * 2008-09-30 2013-08-14 テルモ株式会社 酸性タイプ液状経腸栄養剤
EP2364097B1 (fr) 2008-12-09 2013-01-30 Unilever Plc, A Company Registered In England And Wales under company no. 41424 of Unilever House Confiseries glacées aérées et leur procédé de fabrication
US8241623B1 (en) 2009-02-09 2012-08-14 David Bermudes Protease sensitivity expression system
WO2010144968A1 (fr) * 2009-06-19 2010-12-23 Oral Health Australia Pty Ltd Peptides inhibiteurs de protéase dérivés de la caséine
US8524220B1 (en) 2010-02-09 2013-09-03 David Gordon Bermudes Protease inhibitor: protease sensitivity expression system composition and methods improving the therapeutic activity and specificity of proteins delivered by bacteria
US8771669B1 (en) 2010-02-09 2014-07-08 David Gordon Bermudes Immunization and/or treatment of parasites and infectious agents by live bacteria
US9597379B1 (en) 2010-02-09 2017-03-21 David Gordon Bermudes Protease inhibitor combination with therapeutic proteins including antibodies
WO2012070964A1 (fr) * 2010-11-22 2012-05-31 Farber Boris Slavinovich Oligopeptides modifiés à propriétés anticancereuses et procédé de fabrication
WO2012113037A1 (fr) * 2011-02-25 2012-08-30 The University Of Melbourne Procédé d'inhibition de protéines
US9327026B2 (en) * 2012-04-16 2016-05-03 The Cleveland Clinic Foundation Multivalent breast cancer vaccine
ES2444299B1 (es) * 2012-08-23 2014-12-12 Nutrición Técnica Deportiva, S.L. Uso de un hidrolizado de caseina como agente antiherpético
US9593339B1 (en) 2013-02-14 2017-03-14 David Gordon Bermudes Bacteria carrying bacteriophage and protease inhibitors for the treatment of disorders and methods of treatment
US9138455B2 (en) 2013-03-15 2015-09-22 Mead Johnson Nutrition Company Activating adiponectin by casein hydrolysate
US9289461B2 (en) 2013-03-15 2016-03-22 Mead Johnson Nutrition Company Reducing the risk of autoimmune disease
US8889633B2 (en) 2013-03-15 2014-11-18 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof
US9345727B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component and uses thereof
US9352020B2 (en) 2013-03-15 2016-05-31 Mead Johnson Nutrition Company Reducing proinflammatory response
US20160089400A1 (en) 2013-04-08 2016-03-31 N.V. Nutricia Fermented nutritional composition with thiol protease inhibitor
US20160175351A1 (en) * 2013-06-24 2016-06-23 Duke University Cancer treatment
ES2544153B1 (es) * 2014-02-24 2016-06-06 Ntd Labs, S.L. Uso de un hidrolizado de caseína como agente antiviral
US10676723B2 (en) 2015-05-11 2020-06-09 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
EP3923976A1 (fr) * 2019-02-15 2021-12-22 Rapak, Andrzej Marek Inhibiteurs de peptidases de cystéine isolées à partir de matières premières naturelles et utilisation de ces inhibiteurs en médecine et en médecine vétérinaire
JP6797966B2 (ja) * 2019-04-24 2020-12-09 森永乳業株式会社 胃内酸性プロテアーゼ酵素活性阻害剤、ラクトフェリン組成物の製造方法、及びラクトフェリン組成物
EP4142713A1 (fr) 2020-05-01 2023-03-08 Arjil Biotech Holding Company Limited Composés et méthodes de prévention et de traitement d'infections à coronavirus

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3378279B2 (ja) * 1991-11-07 2003-02-17 株式会社日清製粉グループ本社 ペプチドおよびその製造方法
JPH05184382A (ja) * 1992-01-13 1993-07-27 Kyodo Nyugyo Kk 蛋白分解酵素活性疎外物質の製法
JP3344497B2 (ja) * 1993-03-18 2002-11-11 雪印乳業株式会社 新規システインプロテアーゼインヒビター
JP3460851B2 (ja) * 1993-04-28 2003-10-27 雪印乳業株式会社 新規システインプロテアーゼインヒビター
JP3276753B2 (ja) * 1993-11-12 2002-04-22 大鵬薬品工業株式会社 カテプシンｌ特異的阻害ポリペプチド
JPH07242600A (ja) * 1994-03-02 1995-09-19 Yoshimitsu Nagao チオールプロテアーゼ阻害剤
EP0760674A1 (fr) * 1994-05-26 1997-03-12 Abbott Laboratories Inhibition de l'infection de cellules de mammiferes par le virus respiratoire syncytial
CA2190610A1 (fr) * 1994-05-26 1995-12-07 Pradip Mukerji Inhibition de la fixation de h. influenzae sur des cellules humaines
JP3805804B2 (ja) * 1994-09-14 2006-08-09 森永乳業株式会社 動脈硬化防止剤
JPH09221425A (ja) * 1996-02-13 1997-08-26 Taiho Yakuhin Kogyo Kk チオールプロテアーゼ阻害剤
CA2217729C (fr) * 1996-02-21 2001-04-10 Taiho Pharmaceutical Co., Ltd. Substance fa-70d, procede de fabrication et utilisations
EP0977743A1 (fr) * 1997-04-25 2000-02-09 Smithkline Beecham Inhibiteurs de proteases
JP3643925B2 (ja) * 1998-08-24 2005-04-27 大鵬薬品工業株式会社 Ｆａ−７０ｃ１物質
JP4592127B2 (ja) * 1999-03-30 2010-12-01 雪印乳業株式会社 骨吸収抑制剤
JP2001139534A (ja) * 1999-11-16 2001-05-22 Yoshimitsu Nagao バリン誘導体およびその用途

Also Published As

Publication number Publication date
EP1568377A1 (fr) 2005-08-31
AU2003277644A1 (en) 2004-06-23
JPWO2004050118A1 (ja) 2006-03-30
CA2481489A1 (fr) 2004-06-17
US20050148504A1 (en) 2005-07-07
KR20050044758A (ko) 2005-05-12
WO2004050118A1 (fr) 2004-06-17

Similar Documents

Publication Publication Date Title
NO20044258L (no) Cystein proteaseinhibitor
EP1499336A4 (fr) Inhibiteurs de protease
EP1272467A4 (fr) Inhibiteurs de proteases a cysteine de type cathepsines
ATE461200T1 (de) Inhibitoren von cysteinprotease
IL183308A0 (en) Cathepsin cysteine protease inhibitors
CY2012007I1 (el) Πεπτιδομιμητικοι αναστολεις πρωτεασης
DE60215683D1 (de) Uhrgehäuse
EP1526283A4 (fr) Compresseur
EP1694647A4 (fr) Inhibiteurs des proteases a cysteine du type cathepsine
ITMI20021399A0 (it) Inibitori della cicloossigenasi 2
DK1466962T3 (da) Alkalisk protease
DK1466970T3 (da) Alkalisk protease
EP1663279A4 (fr) Inhibiteurs de protease modifies
AU2003234630A1 (en) Cysteine protease inhibitors
EP1704142A4 (fr) Inhibiteurs de la protease
DK1347044T3 (da) Alkalisk protease
NO20025786L (no) Protaseinhibitorer
AU2003269984A8 (en) Protease inhibitors
NO20025005L (no) Proteaseinhibitorer
DE60309858D1 (de) Kompressor
DE60309988D1 (de) Kompressor
EP1515046A4 (fr) Compresseur spiraloide
AU2003263738A8 (en) Protease inhibitors
NO20032328L (no) Proteaseinhibitorer
AU2003304496A8 (en) Protease inhibitors